Menu
Recruiting NCT07036393

Acupuncture Versus Transcutaneous Electrical Nerve Stimulation on Pain Post Upper Abdominal Surgeries

No phase Interventional Acupuncture Transcutaneous Electrical Nerve Stimulation Pain Upper Abdominal Surgery

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Acupuncture, Transcutaneous electrical nerve stimulation, drugs.
Who it may be relevant to
Registry conditions: Acupuncture, Transcutaneous Electrical Nerve Stimulation, Pain, Upper Abdominal Surgery. Basic parameters: 20 years — 45 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This study was done to: * Determine the therapeutic efficacy of acupuncture as physical therapy approach in minimizing pain post upper abdominal surgeries. * Determine the therapeutic efficacy of transcutaneous electrical nerve stimulation in minimizing pain post upper abdominal surgeries. * Compare the efficacy and safety of Transcutaneous electrical nerve stimulation versus acupuncture in minimizing pain post upper abdominal surgeries.

Detailed description

Postoperative pain is caused by tissue damage from surgical incisions, triggering acute nociceptive activity in sensory nerve endings. Pain sensations reach the brain through dorsal horn, where it is recognized and interpreted. Management modalities include pharmacologic and non-pharmacologic methods. This study aims to provide a guideline on the effect of acupuncture and transcutaneous electrical nerve stimulation on pain reduction after upper abdominal surgeries.

Interventions

  • Other Acupuncture
    Cholecystectomy involves a procedure where patients' spines are kept in position and skin around the acupoints is disinfected with 75% alcohol. Acupuncture treatment is given when patients return to units within 2 hours after surgery. The needles are inserted using disposable sterile needles and manipulated to induce a sense of "De qi" (soreness, numbness, distension, or heaviness). Gastrectomy involves daily acupuncture sessions for 5 consecutive days, starting on postoperative day 1. The needl
  • Other Transcutaneous electrical nerve stimulation
    Patients will receive a transcutaneous electrical nerve stimulation unit (ENNRAF) for up to 48 hours post-surgery, with instructions to self-titrate intensity for pain relief. Postoperative stimulation will be 20-40 milliampere and pulse width 5
  • Other drugs
    analgesics and nonsteroidal anti-inflammatory drugs

Primary outcome measures

  • assessment of change of postoperative quality of recovery [Time frame: At baseline and 4 weeks]
Secondary outcome measures (1)
  • assessment of change of pressure pain threshold [Time frame: At baseline and 4 weeks]

Eligibility criteria

Inclusion criteria

  • Patients who will have pain after upper abdominal surgery.
  • Adult patients will be between 20 and 45 years of age.
  • Both sexes will be included.
  • Patients have no contraindications for acupuncture or transcutaneous electrical nerve stimulation.
  • Patients with good compliance and fit for treatment.
  • This study will be applied on upper abdominal surgeries \[laparoscopic cholecystectomy, Gastrectomy\].
  • Physical therapy will be used for up to 48 hours after surgery or until the time of discharge.

Exclusion criteria

  • Patients with other causes of pain other than that after upper abdominal surgery.
  • Patients who will have any contraindication for both therapies used.
  • Patients with cardiovascular disease, liver, or renal disease.
  • Patients with malignant tumors.
  • Patients with metal or electronic implants.
  • Patients with autoimmune disease.
  • Pregnancy, postpartum period, breastfeeding.
  • Patients with recent injury in the treatment area

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Mansoura international hospital — Al Mansurah

Identifiers

NCT: NCT07036393 · Samar-005748

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗